Covered recipient · General Payments record
SARA M BOTCHLET
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2022–2024
$529.29
- Reported across 29 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $349.21 | 18 |
| Education | $8.45 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $166.58 | 10 |
| Lilly USA, LLC | $72.30 | 4 |
| Galderma Laboratories, L.P. | $53.95 | 3 |
| REVANCE THERAPEUTICS, INC. | $45.45 | 1 |
| Novo Nordisk AS | $19.38 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (19)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $23.82 | 01/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106803379 | CMS |
| ABBVIE INC. | $22.41 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106803381 | CMS |
| ABBVIE INC. | $12.97 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106803383 | CMS |
| ABBVIE INC. | $8.45 | 02/29/2024 | Education | Undisputed | 01/23/2026 | 1106803385 | CMS |
| ABBVIE INC. | $18.91 | 03/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106803387 | CMS |
| ABBVIE INC. | $10.85 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106803389 | CMS |
| ABBVIE INC. | $23.61 | 04/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106803391 | CMS |
| ABBVIE INC. | $12.05 | 06/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106803393 | CMS |
| ABBVIE INC. | $14.32 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106803395 | CMS |
| ABBVIE INC. | $19.19 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106803397 | CMS |
| Galderma Laboratories, L.P. | $16.53 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145344600 | CMS |
| Galderma Laboratories, L.P. | $17.68 | 07/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145344602 | CMS |
| Galderma Laboratories, L.P. | $19.74 | 08/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145344604 | CMS |
| Lilly USA, LLC | $13.56 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135959029 | CMS |
| Lilly USA, LLC | $14.29 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135959031 | CMS |
| Lilly USA, LLC | $19.36 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135903422 | CMS |
| Lilly USA, LLC | $25.09 | 06/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135943588 | CMS |
| Novo Nordisk Inc | $19.38 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100277572 | CMS |
| REVANCE THERAPEUTICS, INC. | $45.45 | 03/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147934655 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.